Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02265120 · ClinicalTrials.gov registry record · NA

Primary Care Providers' Views and Understanding of Current Recommended Guidelines for Cervical Cancer Screening

A NA study, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
1,000
Enrollment target

NCT02265120 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 1,000 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02265120, a NA study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
1,000 participants
Enrollment target

Study Summary

Significant developments have led to a dramatic change in recommendations for cervical cancer screening. The understanding that the Human Papilloma Virus (HPV) is the cause of nearly 100% of cervical cancer cases and the development of new technologies for detection of HPV DNA at time of cervical cancer screening, has produced changes in preventive healthcare policy for this condition. In an unprecedented event, the American College of Obstetrics and Gynecology, the American Cancer Society and the U.S. Preventive Services Task Force recommended dramatic and unified changes in screening utilizing this new framework. No studies of significance have evaluated (since guideline change in 2013), whether primary care providers find the new recommendations authoritative and believe in them, or whether providers understand implementation of these new guidelines given the many decades of contradictory and differing recommendations. For this study, the opinions of primary care providers who care for patients in the 194 federally designated regions of Primary Care provider shortage within California will be studied. Using the California Medical Board database of licensed providers, a questionnaire will be mailed to a random subset. It is anticipated that the analysis will show varying contempt, confusion and compliance with new guidelines exists. Understanding these factors will have beneficial health policy implications in terms of overcoming barriers to these cost-effective, less intrusive, and more accurate health policy guidelines in the prevention and early detection of cervical cancer.

Interventions

  • BEHAVIORAL Questionnaire

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2014-10
Est. Completion 2015-03
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT02265120

The ClinicalTrials.gov registry entry for NCT02265120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.

NCT02265120 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02265120 about?

NCT02265120 is a clinical study titled "Primary Care Providers' Views and Understanding of Current Recommended Guidelines for Cervical Cancer Screening". Significant developments have led to a dramatic change in recommendations for cervical cancer screening. The understanding that the Human Papilloma Virus (HPV) is the cause of nearly 100% of cervical cancer cases and the development of new technologies for detection of HPV DNA at time of cervical ca...

What is the current status of trial NCT02265120?

This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2014-10. Estimated completion is 2015-03.

What interventions are being tested in trial NCT02265120?

The interventions under investigation include: Questionnaire (BEHAVIORAL).

Who is sponsoring clinical trial NCT02265120?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.